NYSE - Delayed Quote • USD
Glaukos Corporation (GKOS)
At close: April 23 at 4:00 PM EDT
After hours: April 23 at 5:05 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 13 | 13 | 14 | 14 |
| Avg. Estimate | -0.58 | -0.51 | -2.09 | -1.29 |
| Low Estimate | -0.68 | -0.57 | -2.32 | -1.85 |
| High Estimate | -0.5 | -0.44 | -1.64 | -0.2 |
| Year Ago EPS | -0.59 | -0.55 | -2.27 | -2.09 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 14 | 14 |
| Avg. Estimate | 79.6M | 87.51M | 356.67M | 445.23M |
| Low Estimate | 76.4M | 84M | 354.71M | 405.3M |
| High Estimate | 82.1M | 89.7M | 360M | 557M |
| Year Ago Sales | 73.9M | 80.4M | 314.71M | 356.67M |
| Sales Growth (year/est) | 7.70% | 8.80% | 13.30% | 24.80% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.57 | -0.55 | -0.55 | -0.55 |
| EPS Actual | -0.59 | -0.55 | -0.5 | -0.63 |
| Difference | -0.02 | 0 | 0.05 | -0.08 |
| Surprise % | -3.50% | 0.00% | 9.10% | -14.50% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.58 | -0.51 | -2.09 | -1.29 |
| 7 Days Ago | -0.58 | -0.51 | -2.09 | -1.29 |
| 30 Days Ago | -0.58 | -0.51 | -2.09 | -1.29 |
| 60 Days Ago | -0.58 | -0.51 | -2.09 | -1.27 |
| 90 Days Ago | -0.55 | -0.48 | -1.91 | -1.16 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | GKOS | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 1.70% | -- | -- | 0.40% |
| Next Qtr. | 7.30% | -- | -- | 9.90% |
| Current Year | 7.90% | -- | -- | 4.30% |
| Next Year | 38.30% | -- | -- | 13.40% |
| Next 5 Years (per annum) | 8.00% | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Mizuho: Neutral to Neutral | 4/11/2024 |
| Reiterates | Truist Securities: Buy to Buy | 4/8/2024 |
| Reiterates | Stifel: Buy to Buy | 4/3/2024 |
| Maintains | Citigroup: Buy to Buy | 3/25/2024 |
| Reiterates | Truist Securities: Buy to Buy | 3/22/2024 |
| Maintains | Wells Fargo: Overweight to Overweight | 2/22/2024 |
Related Tickers
SGHT Sight Sciences, Inc.
5.64
+5.03%
RXST RxSight, Inc.
54.92
+4.93%
CVRX CVRx, Inc.
14.29
-2.72%
CNMD CONMED Corporation
71.31
-1.79%
GMED Globus Medical, Inc.
51.27
+0.04%
LIVN LivaNova PLC
55.02
+1.87%
SILK Silk Road Medical, Inc
17.67
+1.49%
BRKR Bruker Corporation
82.46
+5.65%
UFPT UFP Technologies, Inc.
213.33
+0.12%
ITGR Integer Holdings Corporation
117.91
+1.08%